Status:
WITHDRAWN
Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study
Lead Sponsor:
GlaxoSmithKline
Conditions:
Osteoarthritis
Eligibility:
All Genders
50-85 years
Brief Summary
The aim of this observational study is to compare the use of an extended release paracetamol formulation with standard paracetamol in a cohort of Australian concessional patients with osteoarthritis (...
Detailed Description
This retrospective analysis of physician prescribing data (long-term concessional cohort from the Medicare Australia PBS claims dataset for the time period 2008-2011 (4 years) will compare the use of ...
Eligibility Criteria
Inclusion
- Participants prescribed with a paracetamol product and categorized as a concessional patient
- Participants with new episodes of OA (no history of OA paracetamol in previous 12 months) or suffering from chronic OA (history of OA paracetamol in the previous 12 months)
Exclusion
- Participants with Rheumatoid arthritis or other auto-immune inflammatory conditions
- Participants receiving the following anti-rheumatoid therapies:Immunimodulators such as methotrexate, leflunamide and TNF blockers
- Participants receiving treatment for cancer pain
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02262702
Start Date
January 1 2013
End Date
January 1 2013
Last Update
January 25 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.